Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice

被引：19
|
作者：
Litten, Raye Z. [1 ]
Falk, Daniel E. [1 ]
Ryan, Megan L. [1 ]
Fertig, Joanne [1 ]
Leggio, Lorenzo [2 ,3 ,4 ]
机构：
[1] NIAAA, Bethesda, MD USA
[2] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, NIH, Bethesda, MD USA
[3] NIDA, Medicat Dev Program, NIH, Baltimore, MD USA
[4] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2020年 / 44卷 / 01期
关键词：
Medications; Alcohol Use Disorder; Personalized Medicine; Targets; Screening Models; Medication Use; Health Services; Dissemination; PLACEBO-CONTROLLED TRIAL; ADDICTIONS NEUROCLINICAL ASSESSMENT; CELL-BASED MODELS; DOUBLE-BLIND; NALTREXONE RESPONSE; PRIMARY-CARE; DEPENDENT INDIVIDUALS; EXPRESSION SIGNATURES; RECEPTOR ANTAGONIST; PRECISION MEDICINE;
D O I：
10.1111/acer.14233
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：23 / 35
页数：13
相关论文
共 50 条
  • [1] Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development
    Litten, Raye Z.
    Falk, Daniel E.
    Ryan, Megan L.
    Fertig, Joanne B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 (07) : 1368 - 1379
  • [2] Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder
    Ray, Lara A.
    Bujarski, Spencer
    Roche, Daniel James Olan
    Magill, Molly
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 (09) : 1612 - 1622
  • [3] Medications for treating alcohol use disorder: A narrative review
    Kranzler, Henry R.
    Hartwell, Emily E.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 (07): : 1224 - 1237
  • [4] Advances in Medications and Tailoring Treatment for Alcohol Use Disorder
    Seneviratne, Chamindi
    Johnson, Bankole A.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2015, 37 (01): : 15 - 28
  • [5] Medications for Alcohol Use Disorder
    Winslow, Bradford T.
    Onysko, Mary
    Hebert, Melanie
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (06) : 457 - 465
  • [6] Mining clinical data for novel medications to treat alcohol use disorder
    Rozema, Luke
    Hoyt, Jessica E.
    V. Watts, Bradley
    Shiner, Brian
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 163
  • [7] The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
    De Beaurepaire, Renaud
    Sinclair, Julia M. A.
    Heydtmann, Mathis
    Addolorato, Giovanni
    Aubin, Henri-Jean
    Beraha, Esther M.
    Caputo, Fabio
    Chick, Jonathan D.
    de la Selle, Patrick
    Franchitto, Nicolas
    Garbutt, James C.
    Haber, Paul S.
    Jaury, Philippe
    Lingford-Hughes, Anne R.
    Morley, Kirsten C.
    Muller, Christian A.
    Owens, Lynn
    Pastor, Adam
    Paterson, Louise M.
    Pelissier, Fanny
    Rolland, Benjamin
    Stafford, Amanda
    Thompson, Andrew
    van den Brink, Wim
    Leggio, Lorenzo
    Agabio, Roberta
    FRONTIERS IN PSYCHIATRY, 2019, 9
  • [8] Medications for Alcohol Use Disorder
    Poorman, Elisabeth
    McQuade, Brianna M.
    Messmer, Sarah
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (01) : 71 - 78
  • [9] Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety
    Litten, Raye Z.
    Wilford, Bonnie B.
    Falk, Daniel E.
    Ryan, Megan L.
    Fertig, Joanne B.
    SUBSTANCE ABUSE, 2016, 37 (02) : 286 - 298
  • [10] On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medications
    Nieto, Steven J.
    Grodin, Erica N.
    Ray, Lara A.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (01): : 43 - 54
12345